| First Author | Kariya R | Year | 2014 |
| Journal | Cancer Lett | Volume | 342 |
| Issue | 1 | Pages | 52-9 |
| PubMed ID | 24012878 | Mgi Jnum | J:204517 |
| Mgi Id | MGI:5532760 | Doi | 10.1016/j.canlet.2013.08.045 |
| Citation | Kariya R, et al. (2014) HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-kappaB pathway. Cancer Lett 342(1):52-9 |
| abstractText | Primary effusion lymphoma (PEL) is a non-Hodgkin lymphoma that occurs predominantly in patients with advanced AIDS. In this study, we examined the effect of HIV protease inhibitors, Lopinavir (LPV), Ritonavir (RTV) and Darunavir (DRV) on PEL cell lines in vitro and in vivo. LPV and RTV, but not DRV induced caspase-dependent apoptosis and suppressed NF-kappaB activity by inhibiting IKK phosphorylation in PEL cells. In a PEL xenograft mouse model, LPV significantly inhibited the growth and invasion of PEL cells. These results suggest that LPV may have promise for the treatment and prevention of PEL, which occurs in HIV/AIDS patients. |
